Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

NCT00532246 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Post-Menopausal

Interventions

DRUG: raloxifene
DRUG: Placebo

Sponsor

Eli Lilly and Company